Valuation UCB

Stocks

Market Closed - Euronext Bruxelles 16:55:00 07/10/2026 BST			5-day change	1st Jan Change
203.80 ^EUR	+0.74%		-1.45%	-14.59%

09-30	Merck's experimental skin disease drug succeeds in mid-stage study	RE
09-29	UCB Presents Data From Innovative Myasthenia Gravis Portfolio At AANEM Annual Meeting And MGFA Scientific Session	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,947	13,973	14,969	36,464	45,333	38,857	-	-
Change	-	-26.25%	7.12%	143.6%	24.32%	-14.29%	-	-
Enterprise Value (EV) ¹	19,807	15,973	17,146	37,918	45,326	39,270	37,162	34,661
Change	-	-19.36%	7.34%	121.15%	19.54%	-13.36%	-5.37%	-6.73%
P/E	17.9x	33.4x	44.8x	34.3x	29.1x	20.4x	17x	14.1x
PBR	2.32x	1.58x	1.67x	3.64x	4.18x	3.22x	2.82x	2.34x
PEG	-	-0.6x	-2.2x	0x	0.6x	0.9x	0.8x	0.7x
Capitalization / Revenue	3.28x	2.53x	2.85x	5.93x	5.86x	4.49x	4.04x	3.64x
EV / Revenue	3.43x	2.9x	3.26x	6.16x	5.86x	4.54x	3.87x	3.24x
EV / EBITDA	12.1x	12.7x	12.7x	25.7x	17.2x	12.9x	10.3x	8.18x
EV / EBIT	15x	23.7x	26.1x	45.4x	22.6x	15.9x	12.5x	9.55x
EV / FCF	15.6x	18.4x	38.5x	41.2x	24.6x	20.6x	14.2x	11.3x
FCF Yield	6.42%	5.43%	2.6%	2.43%	4.06%	4.86%	7.03%	8.89%
Dividend per Share ²	1.3	1.33	1.36	1.39	1.45	1.457	1.502	1.534
Rate of return	1.3%	1.81%	1.72%	0.72%	0.61%	0.71%	0.74%	0.75%
EPS ²	5.6	2.2	1.76	5.61	8.2	9.998	12.01	14.48
Distribution rate	23.2%	60.5%	77.3%	24.8%	17.7%	14.6%	12.5%	10.6%
Net sales ¹	5,777	5,517	5,252	6,152	7,741	8,659	9,607	10,682
EBITDA ¹	1,641	1,260	1,349	1,476	2,636	3,053	3,621	4,240
EBIT ¹	1,318	675	657	836	2,009	2,463	2,979	3,630
Net income ¹	1,058	418	343	1,065	1,558	1,928	2,297	2,758
Net Debt ¹	860	2,000	2,177	1,454	-7	412.7	-1,695	-4,196
Reference price ²	100.35	73.56	78.90	192.20	238.60	203.80	203.80	203.80
Nbr of stocks (in thousands)	188,812	189,959	189,721	189,720	189,996	190,663	-	-
Announcement Date	24/02/22	22/02/23	28/02/24	27/02/25	24/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
UCB	20.23x	4.5x	12.77x	0.72%	43.45B
ELI LILLY AND COMPANY	32.87x	11.93x	24.1x	0.6%	1,032B
JOHNSON & JOHNSON	28.34x	6.29x	17.98x	2.1%	614B
ABBVIE INC.	37.73x	7.89x	16.32x	2.6%	471B
MERCK & CO., INC.	103.26x	5.79x	24.59x	2.4%	350B
ROCHE HOLDING AG	19.01x	4.63x	11.48x	2.86%	337B
NOVARTIS AG	19.87x	5.19x	12.84x	3.07%	268B
ASTRAZENECA PLC	20.52x	4.22x	12.02x	2.1%	246B
AMGEN INC.	25.43x	6.65x	11.85x	2.51%	218B
GILEAD SCIENCES, INC.	-43.62x	6.37x	24.89x	2.28%	179B
Average	26.36x	6.35x	16.88x	2.12%	375.83B
Weighted average by Cap.	32.10x	7.63x	18.64x	1.93%